Connect Biopharma Holdings Limited (CNTB)
Nasdaq: CNTB · Pharmaceutical Preparations · San Diego, CA · filing with the SEC since 2020
Who runs Connect Biopharma Holdings Limited
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Quart Barry D
Chief Executive Officer. First filing Mar 2026, latest Mar 16, 2026, 0 filings in all.
Officers reporting now
3
of 8 people with a filing in the last fifteen months
Directors reporting now
5
8 people on the record since 2026
Officerssales are open-market, Oct 1, 2025 to Oct 1, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Quart Barry D | Chief Executive Officer | Mar 2026 | Mar 16, 2026 | none |
| Peraza Lisa | Senior Vice President, Finance | Mar 2026 | Mar 16, 2026 | none |
| Szekeres David Leslie | President | Mar 2026 | Mar 16, 2026 | none |
Directorssales are open-market, Oct 1, 2025 to Oct 1, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Liu Jean I | director | Mar 2026 | Oct 1, 2026 | none |
| Xanthopoulos Kleanthis Gabriel | director | Mar 2026 | Oct 1, 2026 | none |
| Huang James | director | Mar 2026 | Jun 2, 2026 | none |
| Schoeneck James A | director | Mar 2026 | Mar 16, 2026 | none |
| Wilson Karen J | director | Mar 2026 | Mar 16, 2026 | none |
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.